Editions in : № 6

Read/download whole edition in PDF

THE COMPARATIVE STUDY OF THE CYTOSTATIC ACTIVITY AND MECHANISMS OF ACTION OF THE QUINAZOLINE KNOWN DERIVATIVES AND ERLOTINIB (DOXAZOSIN, PRAZOSIN)

5

COMMUNITY-ACQUIRED UNCOMPLICATED PNEUMONIA IN CHILDREN: PARTICULARITIES OF CHANGES OF CYTOKINE MARKERS IN BOYS AND GIRLS IN THE DYNAMICS OF TREATMENT

10

USE OF STERILE HEMOSTATIC MATERIAL SOAKED WITH A SOLUTION OF HEMOSTATIC POWDER BASED ON CHITOSAN WITH LAPAROSCOPIC CHOLECYSTECTOMY IN PATIENTS SUFFERING FROM ACUTE CALCULOUS CHOILECYSTITIS AT THE BACKGROUND OF CHRONIC VIRAL HEPATITIS

16

STUDY OF INFLUENCE OF ANTIBODIES TO CROSS-REACTIVE CARBOHYDRATE DETERMINANTS OF ALLERGENS ON THE POPULATION PROFILE OF PATIENT SENSITIZATION IN THE SOUTH-WESTERN REGION OF UKRAINE

21

COMPARATIVE CHARACTERISTIC OF PATHOMORPHOLOGICAL CHANGES IN THE STROMA OF THE ENDOMETRIUM AND JUNCTIONAL ZONE OF THE UTERUS IN ADENOMYOSIS AND PROLIFERATIVE PROCESSES OF THE ENDOMETRIUM

27

IMPROVING THE METHODS OF INTRAVITAL PATHOMORPHOLOGICAL DIAGNOSIS (AT THE EXAMPLE OF PROSTATE CANCER)

30

ARTICULAR SYNDROME AND QUALITY OF LIFE IN PATIENTS WITH OSTEOARTHRITIS DURING COMORBID COURSE WITH NONALCOHOLIC STEATOHEPATITIS AND OBESITY

35

SUBJECTIVE PERCEPTION OF MENTAL AND SOMATIC DISEASE WITH PATIENTS WITH SCHIZOPHRENIA AT ITS COMBINATION WITH OBESITY

41

DOPPLER LASER FLOWMETRY AS A METHOD OF ESTIMATION OF MICROHEMODYNAMICS OF SKIN IN AREAS OF DAMAGE TO ARTIFICIAL TISSUE AFTER INJURY

46

SURGICAL TREATMENT OF INTRA-ARTICULAR FRACTURES OF THE CALCANEUS

51

THE DYNAMICS OF SPIROGRAPHIC INDICATORS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE STAGE OF EXACERBATION INCLUDING THE COMPLEX TREATMENT OF LYOTHYRONINE

55

PATHOGENETIC JUSTIFICATION OF APPLYING OF AMARANTH OIL FOR PROTECTION OF INJURY OF ADRENAL GLANDS AT SJÖGREN’S SYNDROME

59

THE EFFECTIVENESS OF REHABILITATION THERAPY IN TYMO AND PABLO SYSTEMS

64

WELCOME TO THE SYMPOSIUM "NEW TECHNOLOGIES IN THE DIAGNOSTICS AND TREATMENT OF SEPSIS"

68

MEASLES: THE CAUSATIVE AGENT, FEATURES OF PATHOGENESIS, POSSIBLE COMPLICATIONS, PROPHYLAXIS

69

INFORMATION FOR AUTHORS

75, 78